Clinical Trials Sponsored by Forrest Baker

Total 4512 results

Bayer

Completed

The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib

Pharmacokinetics | Dietary Fats

United States
Bayer

Completed

Clinical Study to Evaluate Safety and Maximum Tolerated Dose of BAY1000394 Given in a 4 Week on / 2 Week Off Schedule in Subjects With Advanced Malignancies

Neoplasms

United States
Bayer

Completed

Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients in Magnetic Resonance Imaging

Magnetic Resonance Imaging

Philippines
Bayer

Completed

Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens

Hemophilia A

Italy, Greece, Germany, Spain, United Kingdom, Sweden
Bayer

Completed

YAZ, Oral Contraceptive Registration in China

Contraception

China, Hong Kong
Bayer

Withdrawn

Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients (CARDINAL)

Hypertension | Diabetic Nephropathies
Bayer

Completed

COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in Slovakia (COUGH)

Hypertension

Slovakia
Bayer

Completed

Avelox in Complicated Skin and Skin Structure Infections (ARTOS)

Skin Diseases, Bacterial

Germany, Indonesia, Korea, Republic of, Saudi Arabia, Philippines, Taiwan, Austria, Bulgaria, Slovenia, Egypt, Greece, Pakistan
Bayer

Completed

BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

Relapsing Remitting MS (RRMS) | Secondary Progressive MS (SPMS)

France, Germany, Korea, Republic of, Saudi Arabia, Spain, Taiwan, Czech Republic, Italy, Jordan, Lebanon, Turkey, Israel, Portugal, Netherlands, Iran, Islamic Republic of
Bayer

Completed

Primovist Regulatory Post Marketing Surveillance (PMS)

Liver

Korea, Republic of
Bayer

Completed

VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis (VICTOR)

Chronic Bronchitis | Disease Exacerbation

China
Bayer

Completed

AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs

Bronchitis, Chronic

Slovakia, Kazakhstan, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Russian Federation, Ukraine, Bosnia and Herzegovina, Albania
Bayer

Completed

Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting (POTASSIUM)

Primary Hypertension

Poland
Bayer

Completed

Treatment of Hypertension With Adalat® in Combination With Other Drugs

Hypertension

Saudi Arabia, Jordan, Lebanon, Russian Federation, Bahrain, Egypt, United Arab Emirates, Morocco, Oman, Qatar, Pakistan
Bayer

Completed

A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ® (PONDIAC)

Carcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)

Belgium
Bayer

Completed

BENEFIT Extension Study

Multiple Sclerosis

Switzerland, Poland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Slovenia, Israel, Belgium, Denmark, Netherlands, Canada, Norway, Finland
Bayer

Completed

Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan (ZEVALIN-SDUI)

Non-Hodgkin's Lymphoma (NHL)

Japan
Bayer

Completed

Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin

Respiratory Tract Infections | Fever

Ukraine, Russian Federation
Bayer

Completed

To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives (DOC)

Contraception

Poland
Bayer

Completed

Study to Investigate Efficacy and Safety of a New Oral Contraceptive

Contraception

Germany, Austria, Spain
Bayer

Completed

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron (START)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

United States
Bayer

Completed

Hypertension Study of Ventavis® Inhalation Therapy in the Treatment of Patients With Pulmonary Arterial Hypertension (VENIS)

Pulmonary Hypertension

Korea, Republic of
Bayer

Completed

Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care

Diabetes Mellitus

Spain
Bayer

Completed

Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

Peripheral Vascular Diseases

Germany, Switzerland, Argentina, Austria, Mexico, Brazil
Bayer

Completed

Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension

Hypertension, Pulmonary

Belgium, France, Spain, Netherlands, Italy, Portugal, Poland
Bayer

Completed

Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment (SONAR)

Hypertension

Romania, Slovakia
Bayer

Completed

Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis

Osteoporosis | Hypogonadism | Paraplegia | Bone Density

Germany
Bayer

Completed

Androcur Effects on Quality of Life

Prostate Cancer

Hungary
Bayer

Completed

BAY14-2222 Continuous Infusion in Surgeries

Hemophilia

Israel
Bayer

Completed

The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension (METABOLIC)

Hypertension

Poland, Slovakia, Croatia, Slovenia
Bayer

Completed

Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of BAY 43-9006

Kidney Diseases
Bayer

Completed

A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception

Contraception

China
Bayer

Completed

Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy

Lymphoma, Non-Hodgkin

Belgium, France, Spain, Italy, Canada, Switzerland, Netherlands, United Kingdom, Portugal, Germany, Sweden, Denmark, Norway
Forest Laboratories

Completed

A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically (LIN-PK-01)

Irritable Bowel Syndrome | Constipation | Breast Feeding

United States
Forest Laboratories

Completed

Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
Forest Laboratories

Completed

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States
Forest Laboratories

Completed

Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine

Autistic Disorder | Autism | Autism Spectrum Disorders | Asperger Syndrome | Asperger's Disorder | Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS)

United States, Belgium, Colombia, Estonia, France, Hungary, Iceland, Italy, Korea, Republic of, New Zealand, Poland, Serbia, South Africa, Spain, Ukraine
Forest Laboratories

Completed

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder

Depression | Bipolar Disorder

United States, Bulgaria, Serbia, Ukraine, Croatia, Romania, Puerto Rico, Slovakia
Forest Laboratories

Completed

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

Depression | Bipolar Disorder

United States, Bulgaria, Poland, Puerto Rico, Lithuania, Estonia
Forest Laboratories

Completed

A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder

Depressive Disorder, Major

United States
Forest Laboratories

Completed

Diafert for Embryo Selection and Fertility Improvement (DESTINy)

Infertility

Belgium
Forest Laboratories

Completed

Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Forest Laboratories

Completed

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections (cSSSI)

Bacterial Infections

Argentina, Chile, Mexico, Russian Federation, United States, Poland, Germany, Brazil, Peru, Romania, Ukraine
Forest Laboratories

Completed

Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia (CAP)

Bacterial Pneumonia

United States, Argentina, Austria, Bulgaria, Chile, Germany, Hungary, India, Latvia, Mexico, Peru, Poland, Romania, Russian Federation, Ukraine
Forest Laboratories

Completed

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections

Bacterial Infections

United States, Chile, Latvia, Poland, Russian Federation, Argentina, Mexico, Austria, Brazil, Germany, Ukraine, United Kingdom
Forest Laboratories

Completed

Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025) (ODO-P8-689)

Nausea
Forest Laboratories

Terminated

Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure

Portal Hypertension

Spain
Forest Laboratories

Withdrawn

Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori

Helicobacter Pylori Infection

United States, Canada
Forest Laboratories

Completed

Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal

Dyspepsia

Canada
Forest Laboratories

Terminated

A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography

Ischemic Heart Disease | Heart Disease

United States

3

Subscribe